3Wanqing Chen,Kexin Sun,Rongshou Zheng,Hongmei Zeng,Siwei Zhang,Changfa Xia,Zhixun Yang,He Li,Xiaonong Zou,Jie He.Cancer incidence and mortality in China, 2014[J].Chinese Journal of Cancer Research,2018,30(1):1-12. 被引量：872
二级参考文献16
1Roberts MJ, Schirra H J, Lavin MF, et al. Metabolomics : a novel approach to early and noninvasive prostate cancer detection[J]. Korean J Urol,2011,52(2) :79-89.
2Chakrabarti R, Robles LD, Gibson J, et al. Profiling of dif ferential expression of messenger RNA in normal, benign, and metastatic prostate cell lines[J]. Cancer Genet Cyto- genet,2002,139(2) : 115-125.
3Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin,2010,60(5):277-300.
4Ploussard G,de la Taille A. Urine biomarkers in prostate cancer[J]. Nat Rev Urol, 2010,7 (2) : 101-109.
5Schwarzenbach H, Alix-Panabieres C, Muller I, et al. Cell- free tumor DNA in blood plasma as a marker for circulat- ing tumor cells in prostate cancer[J]. Clin Cancer Res, 2009,15 (3) :1032-1038.
6Rowley DR,Dang TD,Mcbride L,et al. Beta-2 microglob- ulin is mitogenic to PC-3 prostatic carcinoma cells and an- tagonistic to transforming growth factor beta 1 action[J]. Cancer Res,1995,55(4) :781-786.
7Huang WC, Wu D, Xie Z, et al. Beta2-microglobulin is a signaling and growth promoting factor for human prostate cancer bone metastasis [J]. Cancer Res, 2006, 66 (18) :9108-9116.
8Yang J, Qian J, Wezeman M, et al. Targeting beta2-micro- globulin for induction of tumor apoptosis in human hema- tological malignancies[J]. Cancer Cell, 2006,10 (4) : 295- 307.
